Search

everythinglearnresearchcommunity

for

Search:↓

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Medical treatments for benign prostatic hyperplasia mainly relieve symptoms, while surgery is more effective but not always suitable for elderly patients.

Higher cholesterol levels increase aggressive prostate cancer risk.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

New method detects finasteride in plasma quickly and accurately without clean-up.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Reliable method detects finasteride in human plasma at low doses.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

New method measures finasteride in blood quickly and accurately.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Human scalp hair follicles can be used to study how prolactin affects hair growth and cell death.

Human scalp hair follicles have PGE2 and its receptors, which might affect hair growth.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Men with enlarged prostates often have more severe baldness.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Early hair loss may indicate prostate issues.

Malva verticillata seed extract might help treat hair loss by activating hair growth signals in skin cells.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

Berberine may reduce prostate enlargement by blocking inflammation.